Asunto(s)
Cetotifen/uso terapéutico , Neurofibromatosis 1/tratamiento farmacológico , Adulto , Femenino , Humanos , Cetotifen/administración & dosificación , Cetotifen/efectos adversos , Masculino , Neurofibromatosis 1/diagnóstico , Fenotipo , Piel/patología , Factores de Tiempo , Resultado del Tratamiento , Adulto JovenAsunto(s)
Carcinoma Endometrioide/patología , Neoplasias Endometriales/patología , Endometriosis/patología , Peritoneo/patología , Carcinoma Endometrioide/etiología , Carcinoma Endometrioide/cirugía , Neoplasias Endometriales/etiología , Neoplasias Endometriales/cirugía , Endometriosis/complicaciones , Endometriosis/cirugía , Femenino , Humanos , Luteinización/fisiología , Persona de Mediana Edad , Sistemas Neurosecretores/patología , Peritoneo/cirugía , Resultado del TratamientoRESUMEN
The present article reports for the first time a case of an extrarenal teratoid Wilms tumor in the uterus of a 62-year-old woman. It had triphasic histology with epithelial areas composed of metanephric tubules harboring glomerular structures, adamantine patterns, neural type rosettes, blastema, and a primitive, myxoid type stroma. Abundant heterologous elements such as cartilage, striated muscle, squamous epithelium, and an alpha fetoprotein and TTF1-positive early endodermal epithelium were also present. Immunohistochemistry in Wilms tumor areas showed positivity for markers also indicative of peripheral primitive neuroectodermal tumors such as neuron-specific enolase, CD99, and CD56. However, nuclear positivity for Wilms tumor antigen together with the presence of glomeruli and the absence of endometrioid tumor areas and the organoid arrangement of tissues excluded peripheral primitive neuroectodermal tumors, carcinosarcoma, and teratoma, respectively. Although the diagnosis of female genital tract Wilms tumors is difficult in cases where glomerular structures are lacking, it should be considered because these neoplasms have a better therapeutic response than peripheral primitive neuroectodermal tumors and carcinosarcoma.
Asunto(s)
Teratoma/patología , Neoplasias Uterinas/patología , Tumor de Wilms/patología , Biomarcadores de Tumor/análisis , Carcinosarcoma/diagnóstico , Núcleo Celular/química , Núcleo Celular/patología , Terapia Combinada , Proteínas de Unión al ADN/análisis , Diagnóstico Diferencial , Supervivencia sin Enfermedad , Femenino , Humanos , Persona de Mediana Edad , Tumores Neuroectodérmicos Primitivos/diagnóstico , Teratoma/química , Teratoma/terapia , Factores de Transcripción , Resultado del Tratamiento , Neoplasias Uterinas/química , Neoplasias Uterinas/terapia , Tumor de Wilms/química , Tumor de Wilms/terapiaRESUMEN
BACKGROUND: Laryngeal paragangliomas are very rare neoplasms derived from the superior or inferior laryngeal paraganglia. The paragangliomas of the inferior laryngeal paraganglion, depending on their anatomic variability, can give rise to two different clinical expressions of the same process, namely the so-called thyroid paragangliomas and the inferior laryngeal or subglottic paragangliomas. METHODS: We present a case for which we have not found any previous descriptions of a cervical and subglottictracheal relapse of a thyroid paraganglioma removed 3 years earlier. We review the literature. RESULTS: We have found a total of 22 paragangliomas of the inferior laryngeal paraganglia, 23 including our case. CONCLUSIONS: Thyroid paragangliomas and inferior laryngeal or subglottic paragangliomas should be included under the term "paragangliomas" of the inferior laryngeal paraganglion. These tumors are slow growing, benign, hypervascular, and much more common in middle-aged women. Immunohistochemistry is essential for its diagnosis. Open, conservative surgery is the treatment of choice.